[1. Mensah GA, Wei GS, Sorlie PD, et al. Decline in Cardiovascular Mortality: Possible Causes and Implications. Circ Res. 2017;120:366-380. doi: 10.1161/CIRCRESAHA.116.309115.10.1161/CIRCRESAHA.116.309115]Open DOISearch in Google Scholar
[2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544. doi: 10.1016/S0140-6736(16)31012-1.10.1016/S0140-6736(16)31012-1]Open DOISearch in Google Scholar
[3. Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667-1678. doi: 10.1161/CIRCULATIONAHA.114.008720.10.1161/CIRCULATIONAHA.114.00872026503749]Open DOISearch in Google Scholar
[4. Bajaj S, Shamoon F, Gupta N, et al. Acute ST-segment elevation myocardial infarction in young adults: who is at risk? Coron Artery Dis. 2011;22:238-244. doi: 10.1097/MCA.0b013e3283452e7f.10.1097/MCA.0b013e3283452e7f21407075]Open DOISearch in Google Scholar
[5. Lautamaki A, Airaksinen KEJ, Kiviniemi T, et al. Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study. Atherosclerosis. 2014;235:483-487. doi: 10.1016/j.atherosclerosis.2014.05.953.10.1016/j.atherosclerosis.2014.05.95324953487]Open DOISearch in Google Scholar
[6. Jinnouchi H, Sakakura K, Wada H, et al. Clinical features of myocardial infarction in young Japanese patients. Int Heart J. 2013;54:123-128.10.1536/ihj.54.12323774233]Search in Google Scholar
[7. Oliveira A, Barros H, Maciel MJ, Lopes C. Tobacco smoking and acute myocardial infarction in young adults: a population-based case-control study. Prev Med. 2007;44:311-316. doi: 10.1016/j.ypmed.2006.12.002.10.1016/j.ypmed.2006.12.00217239433]Open DOISearch in Google Scholar
[8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Patients. Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Patients (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-3421.10.1161/circ.106.25.3143]Search in Google Scholar
[9. Chung EH, Curran PJ, Sivasankaran S, et al. Prevalence of metabolic syndrome in patients ≤45 years of age with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol. 2007;100:1052-1055. doi: 10.1016/j.amjcard.2007.05.028.10.1016/j.amjcard.2007.05.02817884360]Open DOISearch in Google Scholar
[10. Singh A, Collins B, Qamar A, et al. Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry. Clin Cardiol. 2017;40:955-961. doi: 10.1002/clc.22774.10.1002/clc.22774576165328805969]Search in Google Scholar
[11. Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R. Long-term prognosis and clinical characteristics of young adults (≤40 years old) who underwent percutaneous coronary intervention. J Cardiol. 2014;64:171-174. doi: 10.1016/j.jjcc.2013.12.005.10.1016/j.jjcc.2013.12.005]Open DOISearch in Google Scholar
[12. Meliga E, De Benedictis M, Gagnor A, Belli R, Scrocca I, Lombardi P. Long-term outcomes of percutaneous coronary interventions with stent implantation in patients ≤40 years old. Am J Cardiol. 2012;109:1717-1721. doi: 10.1016/j.amjcard.2012.01.400.10.1016/j.amjcard.2012.01.400]Open DOISearch in Google Scholar
[13. Berger JS, Eraso LH, Xie D, Sha D, Mohler ER 3rd. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey 1999-2004. Atherosclerosis 2010;213:586-591. doi: 10.1016/j.atherosclerosis.2010.09.010.10.1016/j.atherosclerosis.2010.09.010]Open DOISearch in Google Scholar
[14. Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J. 1998;19:80-84. doi: 10.1053/euhj.1997.0747.10.1053/euhj.1997.0747]Open DOISearch in Google Scholar
[15. Varol E, Aksoy F, Özaydın M, Erdoğan D, Doğan A. Relationship between mean platelet volume and mitral annular calcification. Blood Coagul Fibrinolysis. 2013;24:189-193. doi: 10.1097/MBC.0b013e32835b7296.10.1097/MBC.0b013e32835b7296]Open DOISearch in Google Scholar
[16. Huczek Z, Kochman J, Filipak KJ et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2005;46:284-290. doi: 10.1016/j.jacc.2005.03.065.10.1016/j.jacc.2005.03.065]Open DOISearch in Google Scholar
[17. Tomasz R, Aleksandra J, Jakub F, et al. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J. 2013;20:491-498. doi: 10.5603/CJ.2013.0134.10.5603/CJ.2013.0134]Open DOISearch in Google Scholar
[18. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.10.7326/0003-4819-150-9-200905050-00006]Search in Google Scholar
[19. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.10.1016/0002-9149(67)90023-9]Search in Google Scholar
[20. Sianos G, Papafaklis MI, Serruys PW. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol. 2010;22:6B-14B.]Search in Google Scholar
[21. Kirma C, Izgi A, Dundar C, et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J. 2008;72:716-721.10.1253/circj.72.71618441449]Search in Google Scholar
[22. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Coll Cardiol. 2003;42:954-970.10.1016/S0735-1097(03)01065-9]Search in Google Scholar
[23. Braunwald E. Coronary plaque erosion: recognition and management. JACC Cardiovasc Imaging. 2013;6:288-289. doi: 10.1016/j.jcmg.2013.01.003.10.1016/j.jcmg.2013.01.00323473110]Open DOISearch in Google Scholar
[24. Kolodgie FD, Burke AP, Farb A, et al. Plaque erosion. In: Virmani R, Narula J, Leon MB, Willerson JT, editors. The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management. Boston, MA: Blackwell Publishing, 2007; p. 60-76.10.1002/9780470987575.ch4]Search in Google Scholar
[25. Dai J, Xing L, Jia H, et al. In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study. Eur Heart J. 2018;39:2077-2085. doi: 10.1093/eurheartj/ehy101.10.1093/eurheartj/ehy10129547992]Open DOISearch in Google Scholar
[26. Mincu RI, Jánosi RA, Vinereanu D, Rassaf T, Totzeck M. Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis. Sci Rep. 2017;7:41530. doi: 10.1038/srep41530.10.1038/srep41530527024428128312]Search in Google Scholar
[27. Sawant AC, Adhikari P, Narra SR, Srivatsa SS, Mills PK, Srivatsa SS. Neutrophil to lymphocyte ratio predicts short-and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J. 2014;21:500-508. doi: 10.5603/CJ.a2013.0148.10.5603/CJ.a2013.014824142685]Open DOISearch in Google Scholar
[28. Park JJ, Jang HJ, Oh IY, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111:636-642. doi: 10.1016/j.amjcard.2012.11.012.10.1016/j.amjcard.2012.11.01223273716]Open DOISearch in Google Scholar
[29. Machado GP, Araujo GN, Carpes CK, et al. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Atherosclerosis. 2018;274:212-217. doi: 10.1016/j.atherosclerosis.2018.05.022.10.1016/j.atherosclerosis.2018.05.02229803159]Open DOISearch in Google Scholar
[30. Toprak C, Tabakci MM, Simsek Z, Arslantas U, Durmus HI, Ocal L. Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Postepy Kardiol Interwencyjnej. 2015;11:288-297. doi: 10.5114/pwki.2015.55599.10.5114/pwki.2015.55599467979626677378]Open DOISearch in Google Scholar
[31. Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction. Angiology. 2016;67:336-345. doi: 10.1177/0003319715591751.10.1177/000331971559175126101368]Open DOISearch in Google Scholar
[32. Karataş MB, Çanga Y, Özcan KS, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34:240-244. doi: 10.1016/j.ajem.2015.10.049.10.1016/j.ajem.2015.10.04926585199]Open DOISearch in Google Scholar
[33. Libby P, Pasterkamp G, Crea F, Jang IK. Reassessing the Mechanisms of Acute Coronary Syndromes The “Vulnerable Plaque” and Superficial Erosion. Circ Res. 2019;124:150-160. https://doi.org/10.1161/CIRCRESAHA.118.311098.10.1161/CIRCRESAHA.118.311098644737130605419]Open DOISearch in Google Scholar
[34. Campbell IC, Suever JD, Timmins LH, et al. Biomechanics and inflammation in atherosclerotic plaque erosion and plaque rupture: implications for cardiovascular events in women. PLoS One. 2014;9:e111785. doi: 10.1371/journal.pone.0111785.10.1371/journal.pone.0111785421881825365517]Search in Google Scholar
[35. Niccoli G, Montone RA, Cataneo L, et al. Morphological-biohumoral correlations in acute coronary syndromes: pathogenetic implications. Int J Cardiol. 2014;171:463-466. doi: 10.1016/j.ijcard.2013.12.238.10.1016/j.ijcard.2013.12.23824439867]Open DOISearch in Google Scholar
[36. Ferrante G, Nakano M, Prati F, et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation. 2010;122:2505-2513. doi: 10.1161/CIRCULATIONAHA.110.955302.10.1161/CIRCULATIONAHA.110.95530221126969]Open DOISearch in Google Scholar
[37. Saia F, Komukai K, Capodanno D, Sirbu V, Musumeci G, Boccuzzi G. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI. JACC Cardiovasc Imaging. 2015;8:566-575. doi: 10.1016/j.jcmg.2015.01.018.10.1016/j.jcmg.2015.01.01825890582]Search in Google Scholar
[38. Sianos, G, Papafaklis, MI, Daemen, J. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50:573-583. doi: 10.1016/j.jacc.2007.04.059.10.1016/j.jacc.2007.04.05917692740]Open DOISearch in Google Scholar
[39. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J. 2001;22:1561-1571. doi: 10.1053/euhj.2000.2515.10.1053/euhj.2000.251511492985]Open DOISearch in Google Scholar
[40. Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost. 2009;101:151-156.10.1160/TH08-03-0186]Search in Google Scholar
[41. Funck-Jensen KL, Dalsgaard J, Grove EL, Hvas AM, Kristensen SD. Increased platelet aggregation and turnover in the acute phase of ST-elevation myocardial infarction. Platelets. 2013;24:528-537. doi: 10.3109/09537104.2012.738838.10.3109/09537104.2012.73883823216571]Open DOISearch in Google Scholar
[42. Tschoepe D, Roesen P, Esser J, et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991;17:433-438. doi: 10.1055/s-2007-1002650.10.1055/s-2007-10026501803514]Open DOISearch in Google Scholar
[43. Debili N, Masse JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood. 1993;82:84-95.10.1182/blood.V82.1.84.bloodjournal82184]Search in Google Scholar
[44. Tekbas E, Kara AF, Ariturk Z, et al. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction. Scand J Clin Lab Invest. 2011;71:613-619. doi: 10.3109/00365513.2011.599416.10.3109/00365513.2011.59941621859357]Open DOISearch in Google Scholar
[45. Ranjith MP, DivyaRaj R, Mathew D, George B, Krishnan MN. Mean platelet volume and cardiovascular outcomes in acute myocardial infarction. Heart Asia. 2016;8:16-20. doi: 10.1136/heartasia-2015-010696.10.1136/heartasia-2015-010696489862527326224]Open DOISearch in Google Scholar